Oligonucleotide-functionalized gold nanoparticles for synchronous telomerase inhibition, radiosensitization, and delivery of theranostic radionuclides
<p>Telomerase represents an attractive target in oncology as it is expressed in cancer but not in normal tissues. The oligonucleotide inhibitors of telomerase represent a promising anticancer strategy, although poor cellular uptake can restrict their efficacy. In this study, gold nanoparticles...
Main Authors: | Bavelaar, BM, Song, L, Jackson, MR, Able, S, Tietz, O, Skaripa-Koukelli, I, Waghorn, PA, Gill, MR, Carlisle, RC, Tarsounas, M, Vallis, KA |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Chemical Society
2021
|
Similar Items
-
Radiolabeled oligonucleotides targeting the RNA subunit of telomerase inhibit telomerase and induce DNA damage in telomerase-positive cancer cells
by: Jackson, MR, et al.
Published: (2019) -
Subcellular targeting of theranostic radionuclides
by: Bavelaar, B, et al.
Published: (2018) -
Subcellular Targeting of Theranostic Radionuclides
by: Bas M. Bavelaar, et al.
Published: (2018-09-01) -
111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells
by: Gill, M, et al.
Published: (2018) -
Indium-111 labelling of liposomal HEGF for radionuclide delivery via ultrasound-induced cavitation
by: Owen, J, et al.
Published: (2019)